During the past decade, Auxilio Mutuo Cancer Center conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 4 clinical trials were completed, i.e. on average, 57.1% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Auxilio Mutuo Cancer Center" #1 sponsor was "Auxilio Mutuo Cancer Center" with 8 trials, followed by "Celgene" with 4 trials sponsored, "Spectrum Pharmaceuticals, Inc" with 2 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored and "Eisai Inc." with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Auxilio Mutuo Cancer Center" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Citius Pharmaceuticals" with 1 trials as a collaborator, "Dr. Reddy's Laboratory" with 1 trials as a collaborator, "Genzyme, a Sanofi Company" with 1 trials as a collaborator and "Pharmacyclics LLC." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Auxilio Mutuo Cancer Center" are "Lymphoma" (3 trials), "Inflammatory Breast Carcinoma" (2 trials), "Mantle Cell Lymphoma" (2 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Breast Cancer" (1 trials). Many other conditions were trialed in "Auxilio Mutuo Cancer Center" in a lesser frequency.

Most popular intervention types in "Auxilio Mutuo Cancer Center" are "Drug" (15 trials), "Biological" (2 trials), "Other" (2 trials), "Diagnostic Test" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (4 trials), "Lenalidomide" (3 trials), "lenalidomide" (3 trials), "Placebo" (2 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Auxilio Mutuo Cancer Center" are 16 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Auxilio Mutuo Cancer Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Auxilio Mutuo Cancer Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Auxilio Mutuo Cancer Center, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".